Cesarean Scar Ectopic: A Challenge in Management

Authors

  • Sandy Jaison Consultant, Department of Obstetrics and Gynecology, Cherish Hospital, Chennai, India
  • Monica Charles Junior Doctor, Department of Obstetrics and Gynecology, Cherish Hospital, Chennai, India

DOI:

https://doi.org/10.5281/zenodo.10797772

Keywords:

caesarean scar ectopic, methotrexate

Abstract

Caesarean scar ectopic describes implantation within the myometrium of a prior caesarean delivery scar. Its incidence approximates 1 in 2000 normal pregnancies and has increased along with the caesarean delivery rates. Management includes hysterectomy in those desiring sterilization and fertility preserving options include systemic or locally injected methotrexate. We are reporting a case of G2P1L1 with previous LSCS delivery with diagnosis of Caesarean scar ectopic. The diagnosis was made with Ultrasonography and serial Beta hCG titers and was managed successfully with Methotrexate.

Downloads

Download data is not yet available.

Downloads

Published

08-03-2024

Issue

Vol. 2 No. 11 (2023)

Section

Articles

License

Copyright (c) 2024 Sandy Jaison, Monica Charles

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
S. Jaison and M. Charles, “Cesarean Scar Ectopic: A Challenge in Management”, IJMDES, vol. 2, no. 11, pp. 29–31, Mar. 2024, doi: 10.5281/zenodo.10797772.